Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour

Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour

Tapping into the ability of engineered mesenchymal stem cells (MSCs) to mobilise into the tumour has expanded the scope of cancer treatment. Engineered MSCs expressing tumour necrosis factor (TNF)-related apoptosis inducing ligand (MSC-TRAIL) could serve as a platform for an efficient and targeted f...

Full description

Bibliographic Details
Main Authors: Kamal Shaik Fakiruddin, Nadiah Ghazalli, Moon Nian Lim, Zubaidah Zakaria, Syahril Abdullah
Format: Article
Language:English
Published: MDPI AG 2018-07-01
Series:International Journal of Molecular Sciences
Subjects:
mesenchymal stem cells
TRAIL
apoptosis
sensitisation
cancer stem cells
tumours
Online Access:http://www.mdpi.com/1422-0067/19/8/2188

Internet

http://www.mdpi.com/1422-0067/19/8/2188

Similar Items